Press release MHRA approves GLP –one receptor agonist semaglutide to lessen hazard of serious coronary heart troubles in obese or overweight adults Semaglutide is the very first fat reduction drug approved in the united kingdom as being a preventative therapy for all those with founded cardiovascular diseasegreater coronary heart level. Wegovy® … Read More